IBX Secures Additional Capital — Shareholders Exercise Options

Imagion Biosystems announces on ASX that it has received a total of $18,460.05 for the exercise of 363,201 Listed Options exercisable at 5 cents, expiring on 26 November 2021, and 10,000 Listed Options exercisable at 3 cents, expiring at 28 April 2023.

Please click to review the full announcement at ASX.